4.4 Article

Management of Histoplasmosis by Infectious Disease Physicians

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Diagnostic delays in infectious diseases

Manish Suneja et al.

Summary: This study investigated the diagnostic delays in infectious diseases and found that the failure to consider the diagnosis initially and not ordering appropriate tests were the two most important contributing factors. Unusual clinical presentations and not consulting infectious diseases physicians early enough were also reported as causes of delays.

DIAGNOSIS (2022)

Article Immunology

Voriconazole Versus Itraconazole for the Initial and Step-down Treatment of Histoplasmosis: A Retrospective Cohort

Michael Joshua Hendrix et al.

Summary: In a single-center retrospective cohort study, voriconazole was associated with increased short-term mortality in histoplasmosis compared to itraconazole.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

A comparison of presentations and outcomes of histoplasmosis across patients with varying immune status

Alexander D. Franklin et al.

Summary: This study examines the differences in presentation and outcomes of histoplasmosis based on immune status and dissemination status. Immunocompetent patients with localized disease show fewer typical signs and symptoms, are diagnosed later, but have lower 90-day mortality rates.

MEDICAL MYCOLOGY (2021)

Article Infectious Diseases

Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology

George R. Thompson et al.

Summary: This review provides the latest consensus and practical guidance on global endemic mycoses, aiming to assist clinical decision-making and improve patient prognosis.

LANCET INFECTIOUS DISEASES (2021)

Review Immunology

Potential for Antigen-Specific Tolerizing Immunotherapy in Systematic Lupus Erythematosus

Sean Robinson et al.

Summary: Systemic lupus erythematosus is a chronic complex autoimmune disease that affects multiple organs. Current treatments have increased survival rates but come with complications, making the need for safe and effective treatments urgent. Restoring immunological tolerance shows promise in reducing inflammatory manifestations.

FRONTIERS IN IMMUNOLOGY (2021)

Article Infectious Diseases

Histoplasmosis acquired in Alberta, Canada: an epidemiological and genomic study

Tanis C. Dingle et al.

Summary: Despite not being traditionally considered a region at risk, Alberta in Canada has reported cases of locally acquired histoplasmosis. Cases were linked to exposure to bats or their droppings, and genomic analysis revealed genetic distinctions between locally acquired and imported cases.

LANCET MICROBE (2021)

Review Mycology

Re-drawing the Maps for Endemic Mycoses

Nida Ashraf et al.

MYCOPATHOLOGIA (2020)

Review Oncology

Advances in cancer immunotherapy 2019-latest trends

Stephan Kruger et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Microbiology

Isavuconazole Diffusion in Infected Human Brain

Claire Rouzaud et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

Article Immunology

Multistate Epidemiology of Histoplasmosis, United States, 2011-2014

Paige A. Armstrong et al.

EMERGING INFECTIOUS DISEASES (2018)

Article Immunology

Comparison of Posaconazole and Itraconazole for treatment of Histoplasmosis

Krishna Bobbili et al.

Open Forum Infectious Diseases (2017)

Article Public, Environmental & Occupational Health

High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala

Blanca Samayoa et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)

Article Immunology

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses

George R. Thompson et al.

CLINICAL INFECTIOUS DISEASES (2016)

Article Immunology

Histoplasmosis

Lawrence J. Wheat et al.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)

Article Immunology

Epidemiology of Histoplasmosis Outbreaks, United States, 1938-2013

Kaitlin Benedict et al.

EMERGING INFECTIOUS DISEASES (2016)

Article Microbiology

Histoplasma capsulatum, lung infection and immunity

Michael C. Horwath et al.

FUTURE MICROBIOLOGY (2015)

Review Microbiology

Tissue Penetration of Antifungal Agents

Timothy Felton et al.

CLINICAL MICROBIOLOGY REVIEWS (2014)

Article Immunology

Geographic Distribution of Endemic Fungal Infections among Older Persons, United States

John W. Baddley et al.

EMERGING INFECTIOUS DISEASES (2011)

Review Infectious Diseases

Safety of triazole antifungal drugs in patients with cancer

Simon Cronin et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)

Article Infectious Diseases

Salvage treatment of histoplasmosis with posaconazole

Angela Restrepo et al.

JOURNAL OF INFECTION (2007)

Review Microbiology

Histoplasmosis: a clinical and laboratory update

Carol A. Kauffman

CLINICAL MICROBIOLOGY REVIEWS (2007)

Article Infectious Diseases

Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole

LJ Wheat et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)

Article Infectious Diseases

Activity of posaconazole in the treatment of central nervous system fungal infections

P Pitisuttithum et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)